Prasad Raju
Insider CIK 1968317 · CRSP Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | G Gift | 2026-08-07 | 2026-08-11 | 750 | — | $0 | 14,815 | SEC↗ |
| CRSP CRISPR Therapeutics AG | G Gift | 2026-08-07 | 2026-08-11 | 750 | — | $0 | 14,815 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2026-05-29 | 2026-06-02 | 19,500 | — | $0 | 19,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-03-23 | 2026-03-24 | 3,708 | $46.78 | $173.5K | 15,565 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2026-03-20 | 2026-03-24 | 27,500 | — | $0 | 27,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2026-03-20 | 2026-03-24 | 38,499 | — | $0 | 38,499 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-03-20 | 2026-03-24 | 6,250 | — | $0 | 12,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-03-20 | 2026-03-24 | 6,250 | — | $0 | 19,273 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-03-16 | 2026-03-17 | 4,021 | $48.26 | $194.1K | 13,773 | SEC↗ |
| CRSP CRISPR Therapeutics AG | G Gift | 2026-03-16 | 2026-03-17 | 750 | — | $0 | 13,023 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-03-16 | 2026-03-17 | 5,848 | $48.26 | $282.2K | 17,794 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-03-14 | 2026-03-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-03-14 | 2026-03-17 | 6,875 | — | $0 | 20,625 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-03-14 | 2026-03-17 | 10,000 | — | $0 | 16,767 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-03-14 | 2026-03-17 | 6,875 | — | $0 | 23,642 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-01-22 | 2026-01-26 | 34,972 | — | $0 | 41,667 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-01-22 | 2026-01-26 | 34,972 | $60.19 | $2.10M | 6,767 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-01-22 | 2026-01-26 | 34,972 | $45.15 | $1.58M | 41,739 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-01-06 | 2026-01-08 | 6,339 | — | $0 | 7,493 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2026-01-06 | 2026-01-08 | 23,361 | — | $0 | 76,639 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-01-06 | 2026-01-08 | 18,933 | $60.18 | $1.14M | 17,534 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-01-06 | 2026-01-08 | 5,004 | $60.00 | $300.2K | 12,530 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2026-01-06 | 2026-01-08 | 5,763 | $60.21 | $347.0K | 6,767 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-01-06 | 2026-01-08 | 6,339 | $44.31 | $280.9K | 36,467 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2026-01-06 | 2026-01-08 | 23,361 | $45.15 | $1.05M | 30,128 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2025-12-22 | 2025-12-23 | 5,472 | $56.33 | $308.2K | 7,767 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2025-12-22 | 2025-12-23 | 1,000 | $56.89 | $56.9K | 6,767 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2025-12-22 | 2025-12-23 | 3,528 | $55.10 | $194.4K | 13,239 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2025-10-03 | 2025-10-03 | 16,500 | — | $0 | 16,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2025-05-30 | 2025-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2025-03-21 | 2025-03-24 | 2,197 | $41.23 | $90.6K | 16,767 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2025-03-20 | 2025-03-24 | 6,250 | — | $0 | 18,750 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2025-03-20 | 2025-03-24 | 6,250 | — | $0 | 18,964 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2025-03-17 | 2025-03-18 | 3,762 | $41.80 | $157.3K | 12,714 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2025-03-14 | 2025-03-18 | 10,000 | — | $0 | 20,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2025-03-14 | 2025-03-18 | 36,666 | — | $0 | 36,666 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2025-03-14 | 2025-03-18 | 27,500 | — | $0 | 27,500 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2025-03-14 | 2025-03-18 | 10,000 | — | $0 | 16,476 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2024-10-16 | 2024-10-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2024-10-16 | 2024-10-18 | 18,333 | — | $0 | 18,333 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2024-03-20 | 2024-03-22 | 36,168 | — | $0 | 36,168 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2024-03-20 | 2024-03-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2024-03-15 | 2024-03-18 | 3,524 | $72.69 | $256.2K | 6,476 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise deriv | 2024-03-14 | 2024-03-18 | 10,000 | — | $0 | 30,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | M Exercise | 2024-03-14 | 2024-03-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2023-10-13 | 2023-10-17 | 13,832 | — | $0 | 13,832 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2023-03-14 | 2023-03-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CRSP CRISPR Therapeutics AG | A Award deriv | 2023-03-14 | 2023-03-14 | 40,000 | — | $0 | 40,000 | SEC↗ |